Test Price
3,000 AED✅ Home Collection Available
Solid Tumor Panel Genetic Test – NGS Comprehensive Cancer Gene Analysis
Executive Summary & Core Metrics
Core Metrics & Clinical Assurance
- ✅ Accuracy Guarantee: 99.9% Diagnostic Sensitivity via ISO 9001:2015 Accredited Processing (Cert: INT/EGQ/2509DA/3139).
- ✅ Premium Logistics: VIP Mobile Phlebotomy & Temperature-Controlled Cold-Chain Home Collection (available daily 8 AM – 11 PM).
- ✅ Clinical Guidance: Telephonic Post-Test Clinical Guidance by DHA-licensed specialists.
- ✅ Insurance: Direct Billing Verification via WhatsApp +971 54 548 8731.
Test Overview & Methodology
The Solid Tumor Panel Genetic Test screens 150+ cancer-related genes using whole-blood or extracted DNA to detect somatic and germline mutations guiding targeted therapy, prognosis, and hereditary risk assessment. This test aligns with precision oncology protocols and is performed via Next-Generation Sequencing (NGS) covering full coding regions and splice sites.
| Feature | Our Test (DHA‑Licensed) | Closest Alternative |
|---|---|---|
| Methodology | Next‑Generation Sequencing (NGS) – full coding regions & splice sites | Single‑gene tests or hotspot panels (limited coverage) |
| Turnaround Time | 3–4 weeks (rapid reporting for urgent cases) | 4–6 weeks |
| Pre‑Test Genetic Counselling | Included – pedigree mapping & consent | Often not included or charged separately |
| Home Collection | ISO cold‑chain, 8 AM – 11 PM, UAE‑wide | Limited or no mobile service |
Physician Insight & Safety Protocols
“As a Specialist in Diagnostic Radiology, I understand that facing a possible cancer diagnosis is overwhelming. This comprehensive NGS panel provides clarity at the molecular level, but it must always be interpreted alongside your full clinical picture. Genetic results are not destiny; they are a powerful tool when paired with expert guidance.”
– Mr. Prabhakar Reddy Kalathoor, Specialist Diagnostic Radiology, DHA ID: 61713011
⚠ Medication Advisory
Do not discontinue prescribed medication without consulting your doctor. Certain medications may affect test accuracy or require temporary adjustment under supervision.
🛑 Safety Exclusion Criteria & Red Flags
- Active uncontrolled bleeding or severe anemia (Hb < 8 g/dL) – postpone venipuncture.
- Acute febrile illness or systemic infection – reschedule to avoid compromising DNA quality.
- Known allergy to antiseptic agents or phlebotomy materials – inform the mobile nurse.
- Minors: genetic testing for adult-onset cancers must comply with UAE medical consent regulations under Federal Decree-Law No. 4 of 2016 on Medical Liability.
- If you experience severe pain, fainting, or swelling after blood draw, seek emergency evaluation.
Patient FAQ & Clinical Guidance
1. What genes are analyzed in the Solid Tumor Panel NGS test?
This test comprehensively analyzes DNA from a blood sample to identify genetic mutations linked to solid tumors. It screens 150+ genes including BRCA1/2, EGFR, KRAS, TP53, and many others, helping oncologists select targeted therapies and assess hereditary cancer risks.
2. How should I prepare for sample collection and pre-test counselling?
No fasting is required, but you must disclose all medications and supplements before sample collection. Our pre‑test genetic counselling session will document your family cancer history and explain the test scope, potential findings, and implications.
3. How is my genetic data protected under UAE law?
All genetic data is protected under UAE Federal Decree-Law No. 45 of 2021 on Personal Data Protection (PDPL) and Federal Law No. 2 of 2019 Concerning the Use of Information and Communication Technology in Health Fields. The laboratory operates under ISO 9001:2015 and DHA licensing, with encrypted storage and no data sharing without explicit consent.
UAE Regulatory & Data Privacy Adherence
Regulatory Compliance & Data Privacy
DNA Labs UAE operates under DHA Facility License No. 1143. All patient data is handled in compliance with Federal Decree-Law No. 45 of 2021 on Personal Data Protection (PDPL) and Federal Law No. 2 of 2019 Concerning the Use of Information and Communication Technology in Health Fields. The laboratory is ISO 9001:2015 accredited (Cert: INT/EGQ/2509DA/3139). Genetic information is encrypted and never shared without explicit patient consent.
Clinical & Logistical Metadata
| Test Name | Solid Tumor Panel Genetic Test (NGS Comprehensive Cancer Gene Analysis) |
| Price (AED) | 3,000 AED |
| Turnaround Time | 3–4 weeks (expedited available for urgent referrals) |
| Sample Type / Matrix | Whole blood (peripheral) or extracted DNA; VIP Mobile Phlebotomy & Temperature-Controlled Cold-Chain Home Collection available daily 8 AM – 11 PM |
| Methodology Used | Next-Generation Sequencing (NGS) – full coding regions & splice sites of 150+ cancer-related genes |
| ICD-10-CM Code | Z12.9 (Encounter for screening for malignant neoplasm, site unspecified) |
| LOINC Code | 81247-9 (Oncology gene panel – Master panel) |
| DHA Facility License & Laboratory Address | DHA License No. 1143 | Premises 105, Floor 1, Building 33, Dubai Healthcare City, Dubai, UAE |
دعم ثنائي اللغة متاح
التحقق من التغطية التأمينية
Check Insurance Coverage Instantly
Stop the guesswork. Send a photo of your Insurance Card and Doctor's Prescription to our DHA-Certified Verification Team on WhatsApp.
توقف عن التخمين. أرسل صورة من بطاقة التأمين ووصفة الطبيب إلى فريق التحقق المعتمد من هيئة الصحة بدبي عبر الواتساب. احصل على تحديث الحالة في دقائق.
Available in Arabic, English, Hindi & Urdu
ISMS 27001:2022
ISO Accredited
HIPAA
All reports reviewed by DHA-Certified physicians